Telemedicine
Live-video, remote-monitoring and asynchronous virtual-care platforms sized at $147B-$380B globally by 2025-2030, depending on scope, growing 11%-18% a year.
What this market includes.
The precise boundary of this market and what has deliberately been excluded from it.
Market definition
Telemedicine (used interchangeably here with "telehealth") is the delivery of clinical care -- diagnosis, consultation, monitoring and follow-up -- through live video, audio, remote-monitoring devices or asynchronous (store-and-forward) messaging instead of an in-person visit. It is a subsector of the broader Healthcare Technology market (see parent page) focused specifically on the virtual-care delivery channel rather than the underlying EHR/data infrastructure.
Scope and exclusions
Included: live video/audio consultations, remote patient monitoring (RPM) programs, asynchronous e-visits, and telepsychiatry/tele-specialty services. Excluded: the EHR/health-IT systems telehealth platforms run on top of (see Healthcare Technology), and AI-specific clinical-decision-support tooling (see Healthcare AI). As with the parent market, headline size figures vary substantially by scope (services-only vs. services+platform software; single-country vs. global).
How big it is, and where it is going.
Historical growth, the current market estimate, and forecast scenarios -- shown as ranges, not false precision.
Historical market size
Current market estimate
Not yet available.
Forecast scenarios
What is driving it, on both sides.
The forces increasing or constraining demand, and how supply is structured to meet it.
Demand drivers
- Post-pandemic normalization of virtual visits as a standing (not emergency-only) care channel across primary care, psychiatry and chronic-disease follow-up.
- Payer and employer adoption of telehealth as a standard benefit, reducing per-visit cost relative to in-person care for routine consultations.
- Chronic-disease management demand for remote monitoring integrated with virtual follow-up visits.
- Specialty telehealth (telepsychiatry, telecardiology) identified as the fastest-growing service lines through 2030 across multiple market-research reports.
Supply structure
Teladoc Health is the largest US pure-play telehealth company by revenue (~$640 million quarterly through 2024, per SEC filings), competing against payer-owned virtual-care programs, health-system-run telehealth services, and specialty-focused platforms (telepsychiatry, telederm). The supply side is materially more fragmented than the EHR layer of the broader Healthcare Technology market.
Who buys, who competes, who leads.
Customer segments and how they decide, the competitive landscape, how concentrated it is, and the companies leading it.
Customer segments
- Health insurers/payers distributing telehealth as a covered member benefit.
- Employers offering virtual care as part of employee health benefits.
- Health systems operating telehealth as a service line alongside in-person care.
- Direct-to-consumer patients paying out of pocket for specific virtual-care services (e.g., telepsychiatry, urgent-care video visits).
Customer purchase criteria
Not yet available.
Competitive landscape
Teladoc Health leads by revenue among pure-play telehealth companies but the sector overall is fragmented across payer-owned platforms, health-system in-house telehealth offerings, and specialty-focused entrants (telepsychiatry, telecardiology) that multiple 2025 market reports flag as the fastest-growing service lines.
Market concentration
Not yet available.
Leading companies
How value moves, and who captures it.
The chain from input to end customer, how it reaches them, how it is priced, and the unit economics behind it.
Value chain
Not yet available.
Distribution channels
Not yet available.
Pricing structure
Not yet available.
Unit economics
Not yet available.
What is changing the rules.
The technology trends reshaping this market, the regulatory environment, and a full PESTLE read.
Technology trends
- Integration of remote patient monitoring data directly into live telehealth visits rather than as a separate data stream.
- Growth of asynchronous (store-and-forward) e-visits for lower-acuity conditions, reducing scheduling friction versus live video.
- Specialty telehealth (telepsychiatry, telecardiology) expanding faster than general virtual primary care, per Grand View Research and BCC Research.
Regulatory environment
In the US, telehealth reimbursement parity and cross-state clinician licensure rules are set at both federal (Medicare telehealth flexibilities, subject to periodic Congressional renewal) and state level, creating a patchwork rather than a single national telehealth regulatory regime. Globally, telemedicine falls under the same national digital-health frameworks as the broader Healthcare Technology market (WHO Global Strategy on Digital Health; the EU's European Health Data Space Regulation for any cross-border data handling).
PESTLE analysis
Not yet available.
Where this market is concentrated.
The countries and cities leading this market today.
Leading countries
Leading cities
What sits next to this market.
Emerging niches inside this market, and adjacent markets it connects to.
Emerging niches
Not yet available.
Adjacent markets
Where the openings are, and where to stop.
Market-entry opportunities weighed against the barriers, risks and explicit no-go conditions that should rule an entry out.
Market-entry opportunities
- Specialty telehealth (telepsychiatry, telecardiology, tele-dermatology) service lines, flagged by multiple 2025 market reports as growing faster than general virtual primary care.
- Remote-monitoring-integrated telehealth platforms that combine device data with live visits rather than treating them as separate products.
Barriers to entry
Risks
No-go conditions
Not yet available.
What has just happened.
Recent, dated developments material to how this market is read today.
Recent market events
Not yet available.
Related markets.
Other markets connected to this one through customers, technology or supply chain.
Related markets
Sources and review.
Every important figure on this page is traceable to a dated source. This page was last human-reviewed on 2026-07-15.
Data limitations
Global telemedicine market-size estimates range from $146.9 billion (BCC Research, 2025) to over $380 billion (Grand View Research, 2030 projection) depending on scope and forecast horizon; treat headline figures as scope-dependent, consistent with the parent Healthcare Technology page's broader data-limitations note.
Methodology
This page synthesizes publicly available market-research reports (BCC Research, MarketsandMarkets, Grand View Research, Precedence Research) and one company financial disclosure (Teladoc Health, via SEC filings). It is a lighter-depth companion page to the Healthcare Technology pillar page, which carries the full sourced analysis of the shared regulatory and demand backdrop. Last compiled 2026-07-15.